Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Perspective Therapeutics Stock Price, Quotes and Forecasts
CATXAMEX
Perspective Therapeutics (CATX) Forecast
NewsEarningsPerspective Therapeutics (CATX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Perspective Therapeutics Stock Price, Quotes and Forecasts | AMEX:CATX | Benzinga
Explore Perspective Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CATX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Perspective Therapeutics (CATX) stock?
You can purchase shares of Perspective Therapeutics (AMEX:CATX) through any online brokerage.
Who are Perspective Therapeutics (CATX) competitors?
Other companies in Perspective Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), Monopar Therapeutics (NASDAQ:MNPR) and Sangamo Therapeutics (NASDAQ:SGMO).
What is the forecast, or price target, for Perspective Therapeutics (CATX) stock?
Perspective Therapeutics has a consensus price target of $11.59.
What is the current price for Perspective Therapeutics (CATX)?
The stock price for Perspective Therapeutics (AMEX: CATX) is $2.5 last updated March 5, 2025 at 5:42 PM EST.
Does Perspective Therapeutics (CATX) pay a dividend?
There are no upcoming dividends for Perspective Therapeutics.
When is Perspective Therapeutics (AMEX:CATX) reporting earnings?
Perspective Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is Perspective Therapeutics (CATX) going to split?
There is no upcoming split for Perspective Therapeutics.
What sector and industry does Perspective Therapeutics (CATX) operate in?
Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.